An Act To Prohibit Sale or Possession of Synthetic Cannabinoids
Maine Legislature, Session 126, LD 0661
Committee Amendment CA_A_H422 (House)
Amends: 17-A MRSA §1101, 17-A MRSA §1102

COMMITTEE AMENDMENT" A " to H.P. 453, L.D. 661, Bill, "An Act To 
Prohibit Sale or Possession of Synthetic Cannabinoids" 
Amend the bill by striking out everything after the enacting clause and before the 
summary and inserting the following: 
'Sec. 1. 17-A MRSA §1101, sub-§l-A, as enacted by PL 2011, c. 428, § 1 and 
affected by §9, is repealed. 
Sec. 2. 17-A MRSA §1101, sub-§l-B, as enacted by PL 2011, c. 428, §2 and 
affected by §9, is repealed. 
Sec. 3. 17-A MRSA §1101, sub-§3-A, as enacted by PL 2011, c. 428, §3 and 
affected by §9, is repealed. 
Sec. 4. 17-A MRSA §1101, sub-§3-B, as enacted by PL 2011, c. 428, §4 and 
affected by §9, is repealed. 
Sec. 5. 17-A MRSA §1102, sub-§4, ~F, as enacted by PL 2011, c. 428, §7 and 
affected by §9, is repealed. 
Sec. 6. 17-A MRSA §1102, sub-§4, ~G is enacted to read: 
G. Synthetic cannabinoids, including: 
(I) Tetrahydrocannabinols that are naturally contained in a plant of the genus 
cannabis or a cannabis plant, as well as synthetic equivalents of the substances 
contained in the cannabis plant or in the resinous extractives of cannabis or 
synthetic substances, derivatives and their isomers with similar chemical 
structure and pharmacological activity, including the following: 
(a) Delta-l cis or trans tetrahydrocannabinol and their optical isomers; 
(b) Delta-6 cis or trans tetrahydrocannabinol and their optical isomers; or 
(c) Delta-3.4 cis or trans tetrahydrocannabinol and their optical isomers; 
COMMITTEE AMENDMENT 
~.fb. 
COMMITTEE AMENDMENT "A "to H.P. 453, L.D. 661 
(2) 
Naphthoylindoles, 
including 
any 
compound containing a 
3-0-
naphthoyl)indole structure with substitution at the nitrogen atom of the indole 
ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, l-CN-
methyl-2-piperidinyl)methyl or 2-C4-morpholinyl)ethyl group, whether or not 
further substituted in the indole ring to any extent and whether or not substituted 
in the naphthyl ring to any extent, including the following: 
Ca) I-Pentyl-3-0-naphthoyl)indole or JWH-018 or AM-678; 
(b) I-Butyl-3-(1-napthoyl)indole or JWH-073; 
(c) I-Pentyl-3-e4-methoxy-l-naphthoyl)indole or JWH-081; 
(d) 1-[2-( 4-morpholinyl)ethyl]-3-(I-naphthoyl)indole or JWH-200; 
ee) I-Propyl-2-methyl-3-0-naphthoyl)indole or JWH-015; 
CD I-Hexyl-3-(1-naphthoyl)indole or JWH-019; 
(g) I-Pentyl-3-( 4-methyl-l-naphthoyl)indole or JWH-122; 
(h) I-Pentyl-3-(4-ethyl-l-naphthoyl)indole or JWH-210; 
(i) I-Pentyl-3-(4-chloro-l-naphthoyl)indole or JWH-398; or 
(j) 1-(5-fluoropentyl)-3-0-naphthoyl)indole or AM-2201; 
(3) Naphthylmethylindoles, including any compound containing a H-indol-3-yl-
(l-naphthyl)methane structure with substitution at the nitrogen atom of the indole 
ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, l-(N-
methyl-2-piperidinyl)methyl or 2-C4-morpholinyl)ethyl grOUp, whether or not 
further substituted in the indole ring to any extent and whether or not substituted 
in the naphthyl ring to any extent, including the following: 
Ca) I-Pentyl-1H-indol-3-yl-0-naphthyl)methane or JWH-175; or 
Cb) I-Pentyl-1H-3-yl-(4-methyl-l-naphthyl)methane or JWH-184; 
(4) 
Naphthoylpyrroles, 
including 
any compound containing a 3-0-
naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole 
ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-
morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to 
any extent and whether or not substituted in the naphthyl ring to any extent, 
including (5-(2-fluorophenyl)-l-pentylpyrrol-3-yl)-naphthalen-l-ylmethanone or 
JWH-307; 
(5) Naphthylideneindenes or naphthylmethylindenes, including any compound 
containing a naphthylideneindene structure with substitution at the 3-position of 
the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 
1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or 
not further substituted in the indene ring to any extent and whether or not 
substituted in the naphthyl ring to any extent, 
including E-l-[ 1-0-
Naphthalenylmethylene)-IH-inden-3-yIJpentane or JWH-176; 
COMMITTEE AMENDMENT 
'tv 
.~. 
COMMITTEE AMENDMENT "A "to H.P. 453, L.D. 661 
(6) 
Phenylacetylindoles, 
including 
any 
compound 
contammg 
a 
3-
phenyl acetyl indole structure with substitution at the nitrogen atom of the indole 
ring by an alkyl, halo alkyl, alkenyl, cycloalkylmethyl, cycloalkvlethyl, l-(N-
methyl-2-piperidinynmethyl or 2-(4-morpholinyl)ethyl group, whether or not 
further substituted in the indole ring to any extent and whether or not substituted 
in the phenyl ring to any extent, including the following: 
(a) 1-(2-cyclohexylethyl)-3-(2-methoxypheylacetyl)indole or RCS-8; 
(b) 1-Pentyl-3 -(2-methoxyphenylacetyl)indole or JWH -250; 
(c) I-Pentyl-3-(2-methylphenylacetyl)indole or JWH-251; or 
(d) I-Pentyl-3-(2-chlorophenylacetyl)indole, or JWH-203; 
(7) 
Cyclohexylphenols, including any compound containing a 2-(3-
hydroxycyclohexyl)phenol structure with substitution at the 5-position of the 
phenolic ring by an alkyl, halo alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 
1-(N-methyl-2-piperidinyl)methyl or 2-( 4-morpholinyl)ethyl group, whether or 
not substituted in the cyclohexyl ring to any extent, and their isomers with similar 
chemical structure and phannacological activity, including the following: 
( a) 
5-( 1, I-dimethylheptyl)-2-[( 1 R,3 S)-3 -hydroxycyclohexyl] -phenol or CP 
47,497; 
(b) 
5-( 1 ,l-dimethyloctyl)-2-[( 1 R,3S)-3-hydroxycyclohexyl]-phenol 
or 
Cannabicyclohexanol or CP 47,497-C8 homologue; or 
(c) 
5-( 1, I-dimethylheptyl)-2-[( 1 R,2R)-5-hydroxy-2-(3-
hydroxypropyl)cyclohexyl]-phenol or CP 55,490; 
(8) Benzoylindoles. including any compound containing a 3-(benzoyl)indole 
structure with substitution at the nitrogen atom of the indole ring by an alkyl, 
halo alkyl, 
alkenyl. 
cycloalkylmethyl, 
cycloalkylethyl, 
l-CN-methyl-2-
piperidinyl)methyl or 2-( 4-morpholinyl)ethyl group, whether or not further 
substituted in the indole ring to any extent and whether or not substituted in the 
phenyl ring to any extent, including the following: 
(a) I-Pentyl-3-( 4-methoxybenzoyl)indole or RCS-4; 
Cb) 1-(5-fluoropentyl)-3-C2-iodobenzoyl)indole or AM-694; or 
( c) 
(4-Methoxyphenyl)-[2-methyl-l-(2-( 4-morpholinyl)ethyl)indol-3-
y]methanone or WIN-48,098 or Pravadoline; and 
(9) The following other unclassified synthetic cannabinoids: 
(a) 
(6aR, 1 OaR)-9-Chydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-
6a,7,lO,lOa-tetrahydrobenzo[c]chromen-l-ol or HU-210; 
(b) 
(6aS, 1 OaS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-y1)-
6a,7,lO,lOa-tetrahydrobenzo[c]chromen-l-ol or Dexanabinol or HU-211; 
COMMITTEE AMENDMENT 
~." 
COMMITTEE AMENDMENT "A "to H.P. 453, L.D. 661 
(c) 
2,3-Dihydro-5-methyl-3-( 4-morpholinylmethyl)pyrrolo[1 ,2,3-de ]-1,4-
benzoxazin-6-yl-l-naphthalenylmethanone or WIN 55,212-2; or 
Cd) 
(1-(5-fluoropentyl)-IH-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone or XLR-l1.' 
SUMMARY 
This amendment replaces the bill and amends the Maine Criminal Code to capture the 
larger group of synthetic cannabinoids that have been manufactured since Public Law 
2011, chapter 428 was first enacted. 
The amendment classifies these synthetic 
cannabinoids as Schedule Z drugs. 
!ISCAl.1\OTE REQUIRED 
(See Attached) 
COMMITTEE AMENDMENT 
Fiscal Detail and Notes 
,I'~ 
'I~-!'" 
~ 
~~,~. 
Approved: 06/05/13 
::bYac:.. 
LD661 
LR 1030(02) 
An Act To Prohibit Sale or Possession of Synthetic Cannabinoids 
Fiscal Note for Bill as Amended by Committee Amendment ';4" (J-I- \.f~ ) 
Committee: Criminal Justice and Public Safety 
Fiscal Note Required: Yes 
Fiscal Note 
Minor cost increase - General Fund 
The additional costs to the Department of the Attorney General are expected to be minor and can be absorbed utilizing 
existing budgeted resources. 
LR1030(02) - Fiscal Note - Page 1 of 1